
(MedPage Today) — NEW ORLEANS — A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection fraction improved cardiac function and reduced the risks for serious medical events in a randomized trial…
Source link : https://www.medpagetoday.com/meetingcoverage/aha/118454
Author :
Publish date : 2025-11-11 21:08:00
Copyright for syndicated content belongs to the linked
Source.